stockrow
Friday 6 November 2026
Export LFST’s income statement to Excel — free account
LifeStance Health Group, Inc.
LFST Healthcare Medical Care Facilities
LifeStance Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 13.9% from fiscal 2024.
- Revenue
- +25.3%
- EPS
- +2,042.9%
- Free cash flow
- +31.6%
- Total debt
- −5.15%
Quarter to September 2026, against a year earlier
13.81
0.38
+2.83%
Follow LFST
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
8 | 8 | 7 | — |
| 0.65% | 1.58% | 3.43% | 4.82% | ||
| 0.45% | 1.09% | 2.34% | 3.32% | ||
ROIC |
0.98% | 1.81% | 3.25% | 4.25% | |
Return on Tangible Assets |
2.97% | 8.35% | 18.89% | 25.49% | |
Average Days of Receivables |
24.53 | 30.01 | 25.56 | 26.32 | |
Free Cash Flow per Share |
0.29 | 0.37 | 0.45 | 0.47 | |
Free Cash Flow |
110.03 | 142.63 | 173.91 | 179.27 | |
Capital Expenditures |
(36.12) | (39.72) | (43.96) | (48.33) | |
| Other line items | |||||
Cash ROIC |
5.41% | 7.37% | 8.86% | 9.12% | |
Accounts Receivable Turnover |
12.52 | 11.35 | 13.18 | 13.86 | |
Accounts Payable Turnover |
144.15 | 172.13 | 111.75 | 0.00 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | — | |
Average Days of Payables |
2.32 | 1.55 | 3.83 | 0.00 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | — | |
Tax Rate |
(0.22) | (0.31) | (0.24) | (0.20) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
26.83% | 25.96% | 25.17% | 24.85% | |
Share Based Compensation of Revenue |
5.24% | 4.77% | 4.41% | 4.16% | |
Interest Coverage |
2.07 | 4.32 | 7.75 | 10.63 | |
Operating CF/Net income |
15.12 | 7.86 | 4.31 | 3.17 | |
Depreciation/Fixed assets |
0.35 | 0.34 | 0.34 | 0.34 | |
Capex/Depreciation |
(0.65) | (0.72) | (0.79) | (0.85) | |
Revenue per Share |
3.69 | 3.86 | 4.13 | 4.40 | |
Operating CF per Share |
0.38 | 0.47 | 0.57 | 0.60 | |
Capex per Share |
(0.09) | (0.10) | (0.11) | (0.13) | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.03 |
Columns are period end dates · fundamentals updated 5 Nov 2026